“…In this paper, we described the definition and technical aspects of SABR, clinical outcomes including efficacy and toxicity, and related parameters after SABR in liver oligometastases from colorectal cancer.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There is limited data to support the strategy of Stereotactic Ablative Radiotherapy (SABR) targeting the oligoprogressive disease in combination with ongoing systemic treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Following SABR, there is evidence of systemic immune activation in patients with increased PD1 expression on CD8(+) and CD4(+) T cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Stereotactic ablative radiotherapy (SABR), a recent implementation in the practice of radiation oncology, has been shown to confer high rates of local control in the treatment of early stage non-small-cell lung cancer (NSCLC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, only a proportion of these patients are “true” oligometastatic and therefore derive some kinds of benefit from local ablative approaches like stereotactic ablative radiation therapy (SABR). Since SABR is an easily accessible, effective and well-tolerated treatment, it is widely employed in the oligometastatic scenarios, without a particular focus on selection criteria. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This cohort study investigated the clinical features and risk factors of OP after stereotactic ablative radiotherapy of the lung (SABR). METHODS: Patients undergoing SABR between 2004 and 2010 in two institutions were investigated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Grade 3 or higher toxicity was reported in 13.2% of patients. SABR appears to be a safe and feasible option for SPLCs in patients with prior pneumonectomy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Less than 5 years from diagnosis to SABR and triple‐negative breast cancer (TNBC) were associated with worse OS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…High level evidence from randomized studies comparing stereotactic ablative radiotherapy (SABR) to surgery is lacking. Although the results of pooled analysis of two randomized trials for STARS and ROSEL showed that SABR is better tolerated and might lead to better overall survival than surgery for operable clinical stage Ⅰ non-small cell lung cancer (NSCLC), SABR, however, is only recommended as a preferred treatment option for early stage NSCLC patients who cannot or will not undergo surgery. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Stereotactic ablative radiotherapy (SABR) can deliver tumoricidal doses and achieve long-term control in early hepatocellular carcinoma (HCC). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In the setting of microscopically positive resection margins (R1), adjuvant lung SABR was delivered to all three sites. His treated lung disease remained radiologically stable for up to twenty months after SABR. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We devised a strategy for antigen discovery using SABR libraries to screen thousands of antigenic epitopes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND AND PURPOSE: The optimal stereotactic ablative radiotherapy (SABR) doses for adrenal tumors are unknown. Some trials have specified that organ at risk (OAR) dose constraints should take priority over target coverage. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients were monitored on SABR completion and 1, 4, 8 months later and then subsequently every 6 months. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this review, we summarize clinical evidence from these landmark studies and highlight ongoing trials evaluating the use of LAT/SABR in a variety of clinical contexts along the oligometastatic disease spectrum. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND AND PURPOSE: Magnetic resonance-guided radiotherapy (MRgRT) with real-time intra-fraction tumor motion monitoring allows for high precision Stereotactic Ablative Radiotherapy (SABR). This study aimed to investigate the clinical feasibility, patient satisfaction and delivery accuracy of single-fraction MR-guided SABR in a single day (one-stop-shop, OSS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We sought here to identify predictors of survival and pneumonitis after SABR for NSCLC in a relatively large single-institution series. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Lung metastasis was observed in one patient nine months after SABR; however, the side-effects were generally mild and self-limiting. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Problems identified with the online information related to comprehending medical terminology, understanding the scientific evidence regarding SABR, and appreciating the side-effects associated with SABR. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: This study aimed to evaluate the effect of stereotactic ablative radiotherapy (SABR) after incomplete transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso